The panel will explore why Cambridge is uniquely positioned to become a global leader in AI-driven healthcare innovation, and why that matters not just for patient outcomes, but for the future of the NHS and wider healthcare economy.

The discussion will explore trust and data, from data ownership and access to high-quality datasets, to data sharing between organisations and maintaining public trust alongside how Cambridge's combination of world-leading research, entrepreneurial talent, investment networks and industry partnerships provides a powerful platform for turning breakthrough science into real clinical impact.